Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 5/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5678960 | 1.00 | MGLL (0.35) | MGLLFAAHTRPV1MEN1TP53 | |
| SCHEMBL17833441 | 1.00 | MGLL (0.35) | MGLLFAAHTRPV1MEN1TP53 | |
| SCHEMBL217200 | 1.00 | MGLL (0.35) | MGLLFAAHTRPV1MEN1TP53 | |
| SCHEMBL2289775 | 1.00 | MGLL (0.35) | MGLLFAAHTRPV1MEN1TP53 | |
| SCHEMBL7614182 | 1.00 | MGLL (0.35) | MGLLFAAHTRPV1MEN1TP53 | |
| SCHEMBL11150951 | 0.97 | FAAH (0.33) | MGLLFAAHCYP1A2 | |
| SCHEMBL11150946 | 0.97 | FAAH (0.33) | MGLLFAAHCYP1A2 | |
| SCHEMBL11145323 | 0.95 | FASN (0.33) | MGLLFAAHCYP1A2 | |
| SCHEMBL11145319 | 0.95 | FASN (0.33) | MGLLFAAHCYP1A2 | |
| Acetic Acid SCHEMBL9118623 | 0.93 | FAAH (0.39) | FAAHMEN1TP53CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2249967-B1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITION | INGEVITY SOUTH CAROLINA LLC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-8133970-B2 | Oxidized and maleated derivative compositions | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2012-03-13 | — | — | US | disclosed |
| US-8133970-B2 | Oxidized and maleated derivative compositions | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2012-03-13 | — | — | US | disclosed |
| WO-2009097562-A1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITION | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-08-06 | — | — | WO | disclosed |
| US-20090194731-A1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITIONS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-08-06 | — | — | US | disclosed |
| US-20090194731-A1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITIONS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-08-06 | — | — | US | disclosed |
| US-20090065736-A1 | CHEMICAL MODIFICATION OF MALEATED FATTY ACIDS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-03-12 | — | — | US | disclosed |
| US-20090065736-A1 | CHEMICAL MODIFICATION OF MALEATED FATTY ACIDS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-03-12 | — | — | US | disclosed |
| WO-2009006527-A1 | CHEMICAL MODIFICATION OF MALEATED FATTY ACIDS | GEORGIA-PACIFIC CHEMICALS LLC (US) | 2009-01-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090194731-A1 | OXIDIZED AND MALEATED DERIVATIVE COMPOSITIONS | FASN, TKFC, ELOVL5 | MGLL 99/4885FAAH 2408/4885TRPV1 3635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.